Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Amgen Inc (AMGN)

Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 167,619,840
  • Shares Outstanding, K 536,435
  • Annual Sales, $ 28,190 M
  • Annual Income, $ 6,717 M
  • 60-Month Beta 0.60
  • Price/Sales 5.99
  • Price/Cash Flow 11.94
  • Price/Book 33.62
Trade AMGN with:

Options Overview Details

View History
  • Implied Volatility 18.23% ( -1.44%)
  • Historical Volatility 38.22%
  • IV Percentile 6%
  • IV Rank 10.28%
  • IV High 33.07% on 04/16/24
  • IV Low 16.53% on 09/01/23
  • Put/Call Vol Ratio 0.47
  • Today's Volume 11,903
  • Volume Avg (30-Day) 22,598
  • Put/Call OI Ratio 1.08
  • Today's Open Interest 207,405
  • Open Int (30-Day) 187,481

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 4.87
  • Number of Estimates 12
  • High Estimate 5.12
  • Low Estimate 4.46
  • Prior Year 5.00
  • Growth Rate Est. (year over year) -2.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
260.68 +19.87%
on 04/19/24
322.60 -3.14%
on 05/03/24
+48.40 (+18.33%)
since 04/17/24
3-Month
260.68 +19.87%
on 04/19/24
322.60 -3.14%
on 05/03/24
+28.77 (+10.14%)
since 02/16/24
52-Week
211.71 +47.59%
on 06/01/23
329.72 -5.23%
on 02/05/24
+87.45 (+38.86%)
since 05/17/23

Most Recent Stories

More News
The Dow closed above 40,000 for the first time. The number is big but means little for your 401(k)

Through its long history, the Dow Jones Industrial Average has offered a way for people to get a quick read on how Wall Street is doing

JNJ : 154.64 (+0.23%)
AMGN : 312.47 (-0.71%)
JPM : 204.79 (+1.15%)
GS : 467.72 (+0.69%)
AXP : 242.82 (+0.62%)
MSFT : 420.21 (-0.19%)
INTC : 31.83 (-0.62%)
HON : 205.97 (-0.31%)
$SPX : 5,303.27 (+0.12%)
$DOWI : 40,003.59 (+0.34%)
$IUXX : 18,546.23 (-0.06%)
What Are Wall Street Analysts' Target Price for Amgen Stock?

Amgen has outperformed the broader market and many of its peers over the past year, but Wall Street analysts believe it has limited upside left.

AMGN : 312.47 (-0.71%)
$SPX : 5,303.27 (+0.12%)
BBH : 167.99 (-0.33%)
Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk

Could Amgen be the next stock to soar due to a GLP-1 drug?

NVO : 131.89 (-0.86%)
LLY : 770.00 (-0.15%)
AMGN : 312.47 (-0.71%)
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection

/CNW/ -- USA News Group – Hope is rising in the fight against one of the deadliest cancers in the world, as a new study recently claimed that a blood test can...

ONCY : 1.1100 (-1.77%)
CADL : 11.50 (-9.45%)
ABVC : 1.0700 (+0.94%)
CTMX : 1.8900 (-5.50%)
AMGN : 312.47 (-0.71%)
ONC.TO : 1.51 (-2.58%)
Biotech Innovations Drive Hope in Global Fight Against Pancreatic Cancer

USA News Group – Hope is rising in the fight against one of the deadliest cancers in the world, as a new study recently claimed that a blood test can accurately detect early-stage pancreatic cancer with...

ONCY : 1.1100 (-1.77%)
ONC.TO : 1.51 (-2.58%)
CADL : 11.50 (-9.45%)
ABVC : 1.0700 (+0.94%)
CTMX : 1.8900 (-5.50%)
AMGN : 312.47 (-0.71%)
Amgen Is Working On a Wegovy Competitor -- What It Means for Investors

The biotech's pipeline extends far beyond this exciting weight-loss product.

AMGN : 312.47 (-0.71%)
Stocks Settle Higher on Solid Earnings and Fed Rate Cut Optimism

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +1.03%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.46%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.13%. US stock indexes...

$SPX : 5,303.27 (+0.12%)
SPY : 529.45 (+0.14%)
$DOWI : 40,003.59 (+0.34%)
DIA : 399.95 (+0.33%)
$IUXX : 18,546.23 (-0.06%)
QQQ : 451.76 (-0.05%)
ZNM24 : 109-060s (-0.27%)
SMCI : 887.89 (-1.83%)
NVDA : 924.79 (-1.99%)
AMD : 164.47 (+1.14%)
KLAC : 747.68 (-0.24%)
AVGO : 1,395.29 (-1.19%)
Stocks Climb on Strength in Chips Stocks and Fed Rate Cut Optimism

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.61%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.60%. US stock indexes this morning...

$SPX : 5,303.27 (+0.12%)
SPY : 529.45 (+0.14%)
$DOWI : 40,003.59 (+0.34%)
DIA : 399.95 (+0.33%)
$IUXX : 18,546.23 (-0.06%)
QQQ : 451.76 (-0.05%)
ZNM24 : 109-060s (-0.27%)
MU : 125.29 (-2.03%)
NVDA : 924.79 (-1.99%)
AMD : 164.47 (+1.14%)
GFS : 53.95 (-0.42%)
KLAC : 747.68 (-0.24%)
Stocks Set to Open Higher as Investors Await More Corporate Earnings and Fed Speak

June S&P 500 E-Mini futures (ESM24) are up +0.24%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.18% this morning as market participants looked ahead to a fresh batch of corporate earnings reports...

ESM24 : 5,327.25s (+0.13%)
NQM24 : 18,635.25s (-0.08%)
AMGN : 312.47 (-0.71%)
AAPL : 189.87 (+0.02%)
ANET : 319.89 (-0.06%)
EXPE : 114.01 (+0.49%)
DIS : 103.25 (-0.12%)
TSN : 60.25 (-1.12%)
VRTX : 445.21 (+1.04%)
PLTR : 21.76 (+0.51%)
DDOG : 120.07 (-0.45%)
EA : 127.75 (-1.09%)
Why Amgen Stock Zoomed Nearly 12% Higher Today

The company delivered solid quarterly results, but its discussion of an investigational drug is what really gave its shares a pop.

NVO : 131.89 (-0.86%)
LLY : 770.00 (-0.15%)
AMGN : 312.47 (-0.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 319.95
2nd Resistance Point 317.62
1st Resistance Point 315.04
Last Price 312.47
1st Support Level 310.13
2nd Support Level 307.80
3rd Support Level 305.22

See More

52-Week High 329.72
Last Price 312.47
Fibonacci 61.8% 284.64
Fibonacci 50% 270.71
Fibonacci 38.2% 256.79
52-Week Low 211.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar